MHRA Blog: Decentralised Manufacturing: Emerging Considerations

15th September 2025

MHRA Blog: Decentralised Manufacturing: Emerging Considerations

The MHRA’s MedRegs blog discusses the emerging considerations around decentralised manufacturing of medicines. This approach, which involves producing medicines closer to the point of care rather than in a single central facility, can improve supply chain resilience, reduce delays, and increase patient access to treatments. The blog highlights regulatory challenges, including ensuring consistent quality, managing risk, and maintaining robust oversight across multiple manufacturing sites. It also considers how decentralised models could support innovation, personalised medicine, and global supply security.

Link: Decentralised Manufacturing: Emerging Considerations

Back to Recent News